Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 1/20 | 0.36 |
| ▸ | PTGES2 | Q9H7Z7 | 3/20 | 0.35 |
| ▸ | RXRB | P28702 | 5/20 | 0.33 |
| ▸ | RXRA | P19793 | 4/20 | 0.33 |
| ▸ | RXRG | P48443 | 2/20 | 0.32 |
| ▸ | ICMT | O60725 | 2/20 | 0.32 |
| ▸ | PTGES | O14684 | 2/20 | 0.31 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | CCKAR | P32238 | 2/20 | 0.30 |
| ▸ | CCKBR | P32239 | 2/20 | 0.30 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.30 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26529426 | 0.94 | SCD (0.37) | SCDPTGES2RXRBRXRARXRG | |
| SCHEMBL26529570 | 0.91 | RXRB (0.36) | RXRBRXRARXRGICMTHSD11B1 | |
| SCHEMBL26540655 | 0.90 | ICMT (0.38) | PTGES2RXRBRXRARXRGICMT | |
| SCHEMBL26529467 | 0.88 | RXRB (0.36) | RXRBRXRARXRGICMT | |
| SCHEMBL26529590 | 0.88 | PTGES2 (0.34) | SCDPTGES2ICMT | |
| SCHEMBL26528981 | 0.87 | RXRB (0.37) | RXRBRXRARXRGICMT | |
| SCHEMBL26529579 | 0.87 | MAP4K4 (0.37) | PTGES2ICMTMAP4K4PGR | |
| SCHEMBL26529427 | 0.86 | ICMT (0.33) | RXRBRXRARXRGICMT | |
| SCHEMBL26529486 | 0.86 | RXRB (0.39) | RXRBRXRARXRG | |
| SCHEMBL26529275 | 0.86 | RXRB (0.40) | RXRBRXRARXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | P&h Tech Co., Ltd. (KR) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230329101-A1 | Organic Light Emitting Compound And Organic Light Emitting Device Including Same | ORMDL3, OR10J3, ORC3 | SCD 1714/4885PTGES2 1784/4885RXRB 2498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.